med-mastodon.com is one of the many independent Mastodon servers you can use to participate in the fediverse.
Medical community on Mastodon

Administered by:

Server stats:

365
active users

#SGLT2

0 posts0 participants0 posts today
idw_online<p><a href="https://idw-online.social/tags/NVL" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>NVL</span></a> <a href="https://idw-online.social/tags/Leitlinien" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Leitlinien</span></a> <a href="https://idw-online.social/tags/Herzinsuffizienz" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>Herzinsuffizienz</span></a> <a href="https://idw-online.social/tags/Medikament%C3%B6seTherapie" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>MedikamentöseTherapie</span></a> <a href="https://idw-online.social/tags/SGLT2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SGLT2</span></a>-Inhibitoren <a href="https://idw-online.social/tags/HFpEF" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>HFpEF</span></a></p><p><a href="https://nachrichten.idw-online.de/2023/12/12/version-4-der-nationalen-versorgungsleitlinie-chronische-herzinsuffizienz-veroeffentlicht" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://</span><span class="ellipsis">nachrichten.idw-online.de/2023</span><span class="invisible">/12/12/version-4-der-nationalen-versorgungsleitlinie-chronische-herzinsuffizienz-veroeffentlicht</span></a></p>
Michael Ristow, MD<p><a href="https://mstdn.science/tags/SGLT2" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>SGLT2</span></a> inhibitors mitigate <a href="https://mstdn.science/tags/kidney" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>kidney</span></a> tubular <a href="https://mstdn.science/tags/metabolism" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>metabolism</span></a> and mTORC1 perturbations in type 2 <a href="https://mstdn.science/tags/diabetes" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>diabetes</span></a>. <a href="https://mstdn.science/tags/t2d" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>t2d</span></a> <a href="https://mstdn.science/tags/glucose" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>glucose</span></a> <a href="https://mstdn.science/tags/nephropathy" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>nephropathy</span></a> <a href="https://www.jci.org/articles/view/164486" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://www.</span><span class="">jci.org/articles/view/164486</span><span class="invisible"></span></a> and commentary <a href="https://www.jci.org/articles/view/167700" rel="nofollow noopener noreferrer" target="_blank"><span class="invisible">https://www.</span><span class="">jci.org/articles/view/167700</span><span class="invisible"></span></a></p>
Mohgah Elsheikh<p>ADA Standards of Care in <a href="https://med-mastodon.com/tags/Diabetes" class="mention hashtag" rel="tag">#<span>Diabetes</span></a> 2023 just released. Updates include:<br />Emphasis on supporting up to 15% <a href="https://med-mastodon.com/tags/weight" class="mention hashtag" rel="tag">#<span>weight</span></a> loss<br />New <a href="https://med-mastodon.com/tags/hypertension" class="mention hashtag" rel="tag">#<span>hypertension</span></a> diagnosis cut-offs<br />Role of <a href="https://med-mastodon.com/tags/SGLT2" class="mention hashtag" rel="tag">#<span>SGLT2</span></a> inhibitor use in HFpEF and HFrEF<br />Lower <a href="https://med-mastodon.com/tags/LDL" class="mention hashtag" rel="tag">#<span>LDL</span></a> goals for high-risk individuals</p><p><a href="https://diabetesjournals.org/care/issue/46/Supplement_1" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://</span><span class="ellipsis">diabetesjournals.org/care/issu</span><span class="invisible">e/46/Supplement_1</span></a></p>
Meg Jardine<p>Looking forward to speaking for this free <a href="https://med-mastodon.com/tags/CME" class="mention hashtag" rel="tag">#<span>CME</span></a> session w/ @PlatformQHealth &amp; @goKDIGO on the impact that <a href="https://med-mastodon.com/tags/SGLT2" class="mention hashtag" rel="tag">#<span>SGLT2</span></a> inhibitors can have on the progression of <a href="https://med-mastodon.com/tags/ChronicKidneyDisease" class="mention hashtag" rel="tag">#<span>ChronicKidneyDisease</span></a>! Register now: <a href="https://www.cardiocarelive.com/app/signup/120522_CSLCCL_CME_SGLT2_Reg/formPage/0?refCode=soc_CCL_all_120522_BeyondACEisandARBsFACULTYCOPY" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">cardiocarelive.com/app/signup/</span><span class="invisible">120522_CSLCCL_CME_SGLT2_Reg/formPage/0?refCode=soc_CCL_all_120522_BeyondACEisandARBsFACULTYCOPY</span></a></p>
Silvia Leon<p>New meta-analysis finds <a href="https://med-mastodon.com/tags/SGLT2" class="mention hashtag" rel="tag">#<span>SGLT2</span></a> inhibitors are beneficial in patients with <a href="https://med-mastodon.com/tags/CKD" class="mention hashtag" rel="tag">#<span>CKD</span></a> or <a href="https://med-mastodon.com/tags/HF" class="mention hashtag" rel="tag">#<span>HF</span></a> irrespective of diabetes status. </p><p><a href="https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(22)02074-8/fulltext" target="_blank" rel="nofollow noopener noreferrer" translate="no"><span class="invisible">https://www.</span><span class="ellipsis">thelancet.com/journals/lancet/</span><span class="invisible">article/PIIS0140-6736(22)02074-8/fulltext</span></a></p>